Table 2.
Multivariable* relative risk of colorectal cancer according to total calcium intake in the Nurses’ Health Study (1980–2012) and Health Professionals Follow-up Study (1986–2012)
| Total calcium intake (mg/d) | P-trend | ||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| <600 | 600–<800 | 800–<1000 | 1000–<1200 | 1200–<1400 | ≥1400 | ||
| Colorectal cancer | |||||||
| NHS | |||||||
| No.cases (n=1,828) | 313 | 459 | 397 | 306 | 187 | 166 | |
| Age-adjusted | 1 (ref) | 0.96 (0.83, 1.11) | 0.81 (0.69, 0.94) | 0.75 (0.63, 0.88) | 0.67 (0.56, 0.81) | 0.57 (0.47, 0.69) | <0.001 |
| MVRR | 1 (ref) | 1.00 (0.86, 1.16) | 0.87 (0.74, 1.02) | 0.85 (0.71, 1.01) | 0.80 (0.65, 0.97) | 0.72 (0.58, 0.90) | 0.01 |
| HPFS | |||||||
| No.cases (n=1,250) | 201 | 358 | 270 | 187 | 112 | 122 | |
| Age-adjusted | 1 (ref) | 0.91 (0.76, 1.09) | 0.78 (0.65, 0.94) | 0.83 (0.67, 1.01) | 0.79 (0.63, 1.00) | 0.74 (0.59, 0.92) | 0.01 |
| MVRR | 1 (ref) | 1.00 (0.84, 1.20) | 0.93 (0.76, 1.13) | 1.04 (0.84, 1.28) | 1.01 (0.79, 1.29) | 0.98 (0.76, 1.25) | 0.89 |
| Pooled | |||||||
| No.cases (n=3,078) | 514 | 817 | 667 | 493 | 299 | 288 | |
| Age-adjusted | 1 (ref) | 0.94 (0.84, 1.05) | 0.80 (0.71, 0.89) | 0.78 (0.68, 0.88) | 0.72 (0.61, 0.84) | 0.64 (0.50, 0.83) | 0.01 |
| MVRR | 1 (ref) | 1.00 (0.89, 1.12) | 0.89 (0.79, 1.01) | 0.93 (0.76, 1.13) | 0.89 (0.70, 1.12) | 0.83 (0.62, 1.12) ** | 0.36 |
|
| |||||||
| Colon cancer | |||||||
| NHS | |||||||
| No.cases (n=1,427) | 236 | 361 | 308 | 243 | 144 | 135 | |
| MVRR | 1 (ref) | 1.02 (0.86, 1.21) | 0.86 (0.71, 1.04) | 0.85 (0.70, 1.05) | 0.79 (0.62, 1.00) | 0.75 (0.59, 0.97) | 0.02 |
| HPFS | |||||||
| No.cases (n=996) | 162 | 292 | 212 | 152 | 94 | 84 | |
| MVRR | 1 (ref) | 1.00 (0.82, 1.22) | 0.89 (0.71, 1.10) | 1.02 (0.81, 1.30) | 1.04 (0.79, 1.36) | 0.82 (0.62, 1.09) | 0.43 |
| Pooled | |||||||
| No.cases(n=2,423) | 398 | 653 | 530 | 395 | 238 | 219 | |
| MVRR | 1 (ref) | 1.01 (0.89, 1.15) | 0.87 (0.76, 1.00) | 0.92 (0.78, 1.10) | 0.90 (0.68, 1.17) | 0.78 (0.65, 0.95) ** | 0.05 |
|
| |||||||
| Proximal colon cancer | |||||||
| NHS | |||||||
| No.cases (n=856) | 114 | 201 | 201 | 155 | 92 | 93 | |
| MVRR | 1 (ref) | 1.13 (0.89, 1.44) | 1.12 (0.87, 1.44) | 1.08 (0.82, 1.42) | 0.97 (0.71, 1.33) | 1.00 (0.72, 1.38) | 0.89 |
| HPFS | |||||||
| No.cases (n=426) | 59 | 129 | 99 | 62 | 43 | 34 | |
| MVRR | 1 (ref) | 1.14 (0.83, 1.57) | 1.05 (0.74, 1.48) | 1.00 (0.68, 1.47) | 1.16 (0.76, 1.77) | 0.83 (0.53, 1.31) | 0.47 |
| Pooled | |||||||
| No.cases(n=1,282) | 173 | 330 | 300 | 217 | 135 | 127 | |
| MVRR | 1 (ref) | 1.14 (0.94, 1.37) | 1.09 (0.89, 1.34) | 1.05 (0.84, 1.32) | 1.03 (0.80, 1.33) | 0.94 (0.72, 1.22) | 0.57 |
|
| |||||||
| Distal colon cancer | |||||||
| NHS | |||||||
| No.cases (n=528) | 112 | 147 | 103 | 80 | 48 | 38 | |
| MVRR | 1 (ref) | 0.92 (0.71, 1.19) | 0.65 (0.48, 0.87) | 0.65 (0.47, 0.91) | 0.65 (0.44, 0.95) | 0.53 (0.35, 0.82) | <0.001 |
| HPFS | |||||||
| No.cases (n=364) | 70 | 107 | 67 | 54 | 33 | 33 | |
| MVRR | 1 (ref) | 0.91 (0.66, 1.24) | 0.70 (0.49, 1.01) | 1.00 (0.68, 1.47) | 0.97 (0.63, 1.51) | 0.81 (0.52, 1.28) | 0.79 |
| Pooled | |||||||
| No.cases(n=892) | 182 | 254 | 170 | 134 | 81 | 71 | |
| MVRR | 1 (ref) | 0.91 (0.75, 1.11) | 0.67 (0.53, 0.84) | 0.80 (0.52, 1.22) | 0.78 (0.52, 1.17) | 0.65 (0.43, 0.99) ** | 0.25 |
|
| |||||||
| Rectal cancer | |||||||
| NHS | |||||||
| No.cases (n=401) | 77 | 98 | 89 | 63 | 43 | 31 | |
| MVRR | 1 (ref) | 0.90 (0.66, 1.23) | 0.90 (0.64, 1.25) | 0.84 (0.58, 1.24) | 0.94 (0.61, 1.45) | 0.75 (0.46, 1.23) | 0.31 |
| HPFS | |||||||
| No.cases (n=254) | 39 | 66 | 58 | 35 | 18 | 38 | |
| MVRR | 1 (ref) | 1.02 (0.67, 1.53) | 1.12 (0.73, 1.72) | 1.10 (0.67, 1.79) | 0.90 (0.50, 1.63) | 1.68 (1.02, 2.78) | 0.06 |
| Pooled | |||||||
| No.cases(n=655) | 116 | 164 | 147 | 98 | 61 | 69 | |
| MVRR | 1 (ref) | 0.94 (0.74, 1.21) | 0.97 (0.75, 1.27) | 0.93 (0.69, 1.26) | 0.93 (0.65, 1.31) | 1.12 (0.51, 2.48) ** | 0.79 |
Multivariable relative risks were adjusted for age (in month), race (Caucasian vs. non-Caucasian), adult BMI (< 25, 25 –< 27.5, 27.5 –< 30, or ≥ 30 kg/m2), smoking (0, 1–10, or > 10 pack-years), history of colorectal cancer in a parent or sibling (yes or no), history of sigmoidoscopy/colonoscopy (yes or no), physical activity (< 3, 3–< 27, ≥ 27 MET-hrs/wk), regular aspirin use (yes, no), alcohol consumption (0 –< 5, 5 –< 15, or ≥ 15 g/d), 25-hydroxyvitamin D (25(OH)D) scores (tertiles), current energy-adjusted total intake of, folate, red meat, processed meat (all in tertiles), and postmenopausal hormone use (premenopausal, never, past, or current user; women only).
P-values for heterogeneity by sex were 0.08 for colorectal cancer, 0.67 for colon cancer, 0.64 for proximal colon cancer, 0.19 for distal colon cancer, and 0.03 for rectal cancer.